Ekhtiari, Hamed http://orcid.org/0000-0001-6902-8798
Rezapour, Tara
Sawyer, Brionne
Yeh, Hung-Wen
Kuplicki, Rayus
Tarrasch, Mimi
Paulus, Martin P
Aupperle, Robin
Funding for this research was provided by:
Oklahoma Center for the Advancement of Science and Technology (HR18-139)
Article History
Received: 18 June 2020
Accepted: 13 April 2021
First Online: 7 May 2021
Declarations
:
: The trial was approved by the Western Institutional Review Board as an Independent IRB in WIRB-Copernicus Group Company 1019 39th Avenue SE Suite 120, Puyallup, WA 98374-2115. The NEAT unique study ID in LIBR is 2018-007 with IRB approval number 20181028, 1-1141403-1. The purpose and potential risks of this clinical trial will be fully explained to the participants and their families. All participants will be asked to provide written informed consent before participation.
: Not applicable.
: HE, TR, MP, and RA were involved with the NEAT program development; however, they were all blinded to the assessment procedures or data analysis.